البرزدارو
دالبر | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 18,260 2.99
Close Price: 18,260
Cash Flow
AGM
Interim
2026/05/11 Fiscal Year 2025/12/2112 Month / Audited | 2026/02/19 Fiscal Year 2025/12/2112 Month | ||
|---|---|---|---|
Cash Generated from Operations | 5.108 Trillion | 12.885 Trillion | |
Income Taxes Paid | -383.169 Billion | -383.169 Billion | |
Net Cash Flow from Operating Activities | 4.725 Trillion | 12.502 Trillion | |
Proceeds from Sale of Property, Plant and Equipment | - | 2.57 Billion | |
Purchases of Property, Plant and Equipment | -2.47 Trillion | -2.589 Trillion | |
Proceeds from Sale of Long-Term Investments | 4.864 Trillion | 446.553 Billion | |
Cash Paid to Acquire Long-Term Investments | -2.18 Trillion | -1.336 Trillion | |
Cash Received from Income on Other Investments | 563 Million | 563 Million | |
Net Cash Flow from Investing Activities | 215.29 Billion | -3.476 Trillion | |
Net Cash Flow before Financing Activities | 4.94 Trillion | 9.026 Trillion | |
دریافت های نقدی حاصل از افزايش سرمایه | 388.471 Billion | 388.471 Billion | |
Proceeds from Sale of Treasury Shares | 82.938 Billion | 82.938 Billion | |
Purchases of Treasury Shares | -65.243 Billion | -65.243 Billion | |
Cash Received from Borrowings | 35.511 Trillion | 35.481 Trillion | |
Repayments of Borrowings (Principal) | -28.682 Trillion | -32.347 Trillion | |
Interest Paid on Borrowings | -8.199 Trillion | -8.199 Trillion | |
Dividends Paid | -1.556 Trillion | -1.932 Trillion | |
Net Cash Flow from Financing Activities | -2.52 Trillion | -6.592 Trillion | |
Net Increase (Decrease) in Cash | 2.42 Trillion | 2.435 Trillion | |
Cash at Beginning of Period | 673.792 Billion | 673.792 Billion | |
Effect of Exchange Rate Changes | 203.579 Billion | -5.229 Billion | |
Cash at End of Period | 877.371 Billion | 668.563 Billion | |
Non-Cash Transactions | 6.458 Trillion | - |